The U.S. Preventive Services Task Force now recommends screening for
hepatitis B virus (HBV) infection in high-risk groups, given the
accuracy of serologic testing and the effectiveness of antiviral
therapy.

High-risk groups include:

People born in areas with an HBV prevalence of 2% or more, including
Africa, Asia, the Middle East, Eastern Europe, and parts of South
America;
HIV-positive patients
Injection-drug users
Men who have sex with men
Household contacts of HBV-infected patients
Pregnant women

USPSTF recommendation statement in the Annals of Internal Medicine